UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
An insulin growth factor-I/II-neutralizing monoclonal antibody in combination with epidermal growth factor receptor inhibitors potently inhibits tumor cell growth Journal article
Ma, Guofang, Tan, Chengyue, Shan, Yaming, Shao, Ningyi, Wang, Feng, Dimitrov, Dimiter S., Wang, Liping, Zhao, Qi. An insulin growth factor-I/II-neutralizing monoclonal antibody in combination with epidermal growth factor receptor inhibitors potently inhibits tumor cell growth[J]. Journal of Cancer, 2022, 13(5), 1830-1836.
Authors:  Ma, Guofang;  Tan, Chengyue;  Shan, Yaming;  Shao, Ningyi;  Wang, Feng; et al.
Favorite | TC[WOS]:4 TC[Scopus]:4  IF:3.3/3.3 | Submit date:2022/05/17
Egfr  Gefitinib  Igf-i  Igf-ii  M708.5  Monoclonal Antibody  
Human monoclonal antibody fragments binding to insulin-like growth factors I and II with picomolar affinity Journal article
Zhao, Q., Feng, Y., Zhu, Z., Dimitrov, D.. Human monoclonal antibody fragments binding to insulin-like growth factors I and II with picomolar affinity[J]. Molecular cancer therapeutics, 2011, 1677-1685.
Authors:  Zhao, Q.;  Feng, Y.;  Zhu, Z.;  Dimitrov, D.
Favorite |   IF:5.3/5.4 | Submit date:2023/08/30
monoclonal antibody  IGF-I  IGF-II